1. Home
  2. DBL vs CNXU Comparison

DBL vs CNXU Comparison

Compare DBL & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleLine Opportunistic Credit Fund of Beneficial Interest

DBL

DoubleLine Opportunistic Credit Fund of Beneficial Interest

HOLD

Current Price

$14.03

Market Cap

285.5M

Sector

N/A

ML Signal

HOLD

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

N/A

Current Price

$7.55

Market Cap

282.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DBL
CNXU
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
285.5M
282.3M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
DBL
CNXU
Price
$14.03
$7.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
71.9K
118.4K
Earning Date
01-01-0001
N/A
Dividend Yield
8.67%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.95
$7.30
52 Week High
$16.01
$13.66

Technical Indicators

Market Signals
Indicator
DBL
CNXU
Relative Strength Index (RSI) 40.18 32.40
Support Level $13.95 N/A
Resistance Level $14.42 $11.45
Average True Range (ATR) 0.09 1.29
MACD -0.01 -0.20
Stochastic Oscillator 37.84 6.40

Price Performance

Historical Comparison
DBL
CNXU

About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest

Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Share on Social Networks: